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Electrical coupling via gap junctions is an abundant phenomenon in the mammalian
retina and occurs in all major cell types. Gap junction channels are assembled from
different connexin subunits, and the connexin composition of the channel confers
specific properties to the electrical synapse. In the mouse retina, gap junctions
were demonstrated between intrinsically photosensitive ganglion cells and displaced
amacrine cells but the underlying connexin remained undetermined. In the primary
rod pathway, gap junctions play a crucial role, coupling AII amacrine cells among
each other and to ON cone bipolar cells. Although it has long been known that
connexin36 and connexin45 are necessary for the proper functioning of this most
sensitive rod pathway, differences between homocellular AII/AII gap junctions and
AII/ON bipolar cell gap junctions suggested the presence of an additional connexin
in AII amacrine cells. Here, we used a connexin30.2-lacZ mouse line to study the
expression of connexin30.2 in the retina. We show that connexin30.2 is expressed in
intrinsically photosensitive ganglion cells and AII amacrine cells. Moreover, we tested
whether connexin30.2 and connexin36—both expressed in AII amacrine cells—are able
to interact with each other and are deposited in the same gap junctional plaques.
Using newly generated anti-connexin30.2 antibodies, we show in HeLa cells that
both connexins are indeed able to interact and may form heteromeric channels: both
connexins were co-immunoprecipitated from transiently transfected HeLa cells and
connexin30.2 gap junction plaques became significantly larger when co-expressed with
connexin36. These data suggest that connexin36 is able to form heteromeric gap
junctions with another connexin. We hypothesize that co-expression of connexin30.2
and connexin36 may endow AII amacrine cells with the means to differentially regulate
its electrical coupling to different synaptic partners.
Keywords: connexin, gap junction, primary rod pathway, amacrine cell, melanopsin, ganglion cell, electrical
synapse, ipRGC
Abbreviations: Cx, connexin; GCL, ganglion cell layer; INL, inner nuclear layer; IPL, inner plexiform layer; ipRGC,
intrinsically photosensitive retinal ganglion cell; PB, phosphate buffer; PFA, paraformaldehyde.
Frontiers in Molecular Neuroscience | www.frontiersin.org 1 May 2016 | Volume 9 | Article 36
Meyer et al. Cx30.2 Interactions and Retinal Expression
INTRODUCTION
In the central nervous system, electrical synapses (gap junctions)
constitute a fast means of intercellular communication, directly
transmitting electrical signals from one adjacent cell to another.
Gap junction channels consist of two hemichannels (connexons),
each of which is provided by one cell and formed by a hexamer
of connexin (Cx) subunits (Kumar and Gilula, 1996). In the
mouse genome, 20 connexin isoforms have been identified
(Söhl and Willecke, 2003). Some of these isoforms are able to
associate to form heteromeric connexons or heterotypic gap
junction channels, with hemi-channel composition differing
between the two adjacent cells. As the connexin composition
determines the permeability and gating properties of a gap
junction channel, a great variety in physiological properties
is achieved, which is further enhanced by posttranslational
modifications, such as phosphorylation (Söhl and Willecke,
2003).
Gap junctions are found throughout the entire central
nervous system but in the retina they are particularly abundant
because all major cell types in the retina form coupled networks
(Vaney, 1991). In the mouse retina, five different connexin
isoforms have been identified in neurons: (1) Cx36, expressed
in cone photoreceptors (Feigenspan et al., 2004; Bolte et al.,
2015), bipolars (Deans et al., 2002; Han and Massey, 2005),
amacrine cells (Feigenspan et al., 2001; Brüggen et al., 2015)
and many types of ganglion cells (Pan et al., 2010); (2) Cx45,
expressed in bipolar (Maxeiner et al., 2005; Dedek et al., 2006;
Hilgen et al., 2011), amacrine (Dedek et al., 2009) and bistratified
ganglion cells (Schubert et al., 2005); (3,4) Cx50 and Cx57, both
expressed in horizontal cells (Hombach et al., 2004; Dorgau et al.,
2015); and (5) Cx30.2, expressed in six types of ganglion cells
and an as yet uncharacterized amacrine cell type (Müller et al.,
2010a).
In the retina, gap junctions were shown to improve signal-to-
noise (DeVries et al., 2002), synchronize firing in ganglion cells
(Völgyi et al., 2013) and relay signals into different pathways.
Recently, electrical recordings in the rat retina revealed that
the melanopsin-expressing, intrinsically photosensitive retinal
ganglion cells (ipRGC) are coupled to spiking ON amacrine
cells, allowing ipRGCs to propagate their tonic photoresponses
to amacrine cells via gap junctions (Reifler et al., 2015). The
connexins underlying these electrical synapses in ipRGCs have
not yet been identified, but Cx30.2 was suggested to account for
the tracer coupling between ipRGCs and GABAergic wide-field
amacrine cells (Müller et al., 2010b).
Gap junctions are also critical elements of the primary rod
pathway in which rod signals are relayed onto cone pathways by
AII amacrine cells. AII cells form gap junctions with two synaptic
partners (Hartveit and Veruki, 2012): homocellular gap junctions
with other AII cells and heterocellular gap junctions with ON
cone bipolar cells. While it has long been known that both
types of gap junctions crucially depend on Cx36 (Güldenagel
et al., 2001; Deans et al., 2002), some findings suggest the
presence of another connexin in AII amacrine cells: homo- and
heterocellular gap junctions are differentially modulated (Mills
and Massey, 1995) and assembled (Meyer et al., 2014), and
appear different in electron micrographs (Anderson et al., 2011).
Despite these observations, previous studies implicated Cx36 in
the establishment of homomeric connexons only (Teubner et al.,
2000; Li et al., 2008) although some studies have suggested the
co-expression of Cx45 in AII amacrine cells (Maxeiner et al.,
2005; Li et al., 2008). However, Cx36 and Cx30.2 were shown to
be co-expressed in inhibitory interneurons in the hippocampus
(Kreuzberg et al., 2008), we therefore speculated that Cx30.2
and Cx36 may interact and co-assemble in AII amacrine cells.
Therefore, we used a Cx30.2lacZ mouse line (Kreuzberg et al.,
2006) to extend our studies on Cx30.2 expression in the mouse
retina.
We show that Cx30.2 is expressed in ipRGCs and AII
amacrine cells of the mouse retina. Moreover, we reveal
interaction of Cx36 and Cx30.2 in transfected HeLa cells
suggesting that Cx36 is able to form heteromeric gap junctions
with another connexin. We propose that this may provide
the basis for the differential regulation of Cx36-containing
heterocellular and homocellular gap junctions in AII amacrine
cells.
MATERIALS AND METHODS
Unless mentioned otherwise, reagents and chemicals were
purchased from Roth (Karlsruhe, Germany).
Constructs and HeLa Cell Transfections
Full-length Cx30.2 and Cx36 constructs (mouse sequences),
untagged or tagged with enhanced green-fluorescent protein
(EGFP), were cloned in pRK5 (BD Pharmingen, San Diego,
CA, USA; Helbig et al., 2010). All constructs were sequenced
for accuracy. HeLa cells were transiently transfected with the
calcium-phosphate precipitation method. Briefly, 24 h before
transfection, HeLa cells were plated at a density of 1 × 105 in a
6 cm diameter dish including two coverslips, in 5 ml Dulbecco’s
Modified Eagle Medium (Biochrom GmbH, Berlin, Germany),
supplemented with 10% fetal bovine serum (Biochrom). For
transfection, precipitation solution, including 25 µg/ml DNA,
was applied 48 h before cell lysis. For co-expression of connexin
constructs, cells were transfected with a plasmid mixture
containing equal amounts of both constructs.
Reverse Transcription Polymerase Chain
reaction (RT-PCR)
Retinal total RNA was extracted using the TriFastTM reagent
(PeqLab, Erlangen, Germany) according to the manufacturer’s
instructions. Residual genomic DNA contamination was
eliminated by treatment with DNaseI (Amplification Grade;
Invitrogen, Darmstadt, Germany). The first-strand cDNA
synthesis was carried out using 1 µg of total RNA, 1× first-
strand buffer (Invitrogen), Oligo(dT)15 primer (20 ng/µl;
Promega, Mannheim, Germany), dNTPs (0.4 mM each;
Carl Roth, Karlsruhe, Germany), RiboLock RNase Inhibitor
(1.6 U/µl; Thermo Fisher Scientific, Schwerte, Germany) and
SuperScript III reverse transcriptase (8 U/µl) according to the
manufacturer’s manual. Forty nanogram of the transcribed
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cDNA were subsequently used as PCR template in reaction
buffer (Qiagen, Hilden, Germany) containing MgCl2 (1.5 mM),
0.2 mM dNTPs (Carl Roth), 0.4 µM primer and HotStar
Taq polymerase (0.5 U/µl; Qiagen). The quality of the cDNA
was tested using intron-spanning primers for β-actin (usp:
5′-tgttaccaactgggacgaca-3′; dsp: 5′-aaggaaggctggaaaagagc-3′;
product size: 573 bp for cDNA and 1027 bp for gDNA). To
amplify partial Cx30.2 cDNA, a specific primer set (usp: 5′-
atgcaccaggccagcaaggag-3′; dsp: 5′-ccgcgctgcgatggcaaagag-3′;
product size: 422 bp) and 1× Q-solution (Qiagen) was used.
Generation of Anti-Connexin30.2
Antibodies
Cx30.2 antibodies were raised in rabbit and guinea pig
(Pineda Antibody Service, Berlin, Germany). The peptides
used for immunization comprised the last 20 amino acids
of the C-terminal end of mouse Cx30.2 (rabbit antibodies)
or amino acids 92–109 of mouse Cx30.2, which form part of
the cytoplasmic loop (guinea pig antibodies). Antibodies were
affinity-purified using the immunization peptides.
Immunoprecipitation and Western Blot
Analysis
Immunoprecipitation (IP) experiments were performed using
the µMACS™GFP Isolation Kit (Miltenyi Biotec GmbH,
Bergisch Gladbach, Germany) following the manufacturer’s
instructions. HeLa cells were harvested 48 h after transfection
and homogenized in 350 µl IP buffer, containing 0.5% NP-40,
20 mM Tris, 60 mM NaCl (pH 7.4), and phosphatase and
protease inhibitors (Roche Diagnostics, Mannheim, Germany).
Homogenates were incubated for 1 h on ice and centrifuged
for 10 min at 10,000 g at 4◦C. The supernatant was removed
and incubated for 30 min with 20 µl of magnetic beads which
were covalently coupled to an anti-GFP antibody (Table 1).
After several washes, adsorbed proteins were eluted with
pre-heated (95◦C) elution buffer, containing 50 mM Tris
HCl (pH 6.8), 50 mM DTT, 1% SDS, 1 mM EDTA, 0.005%
bromophenol blue, 10% glycerol. SDS-PAGE (10% gels)
and Western blot analysis were performed with solubilized
(extracted) membrane proteins and precipitates prepared
from HeLa cell homogenates. Enhanced chemiluminescence-
mediated immunodetection was carried out following a standard
protocol. Nitrocellulose membranes were incubated with
primary antibodies (Table 1) diluted in TBS-Tween (20 mM
Tris/HCl, 150 mM NaCl, 0.2% Tween, pH 7.4) overnight at
4◦C. Immunoreactive proteins were visualized using horseradish
peroxidase-conjugated secondary antibodies (1:2000–1:3000,
diluted in TBS-Tween with 2% powdered milk; BioRad, Munich,
Germany) and the Enhanced Chemiluminescence Detection
kit (Pierce, Rockford, IL, USA), following the manufacturer’s
instructions.
Animals and Tissue Preparation
All procedures were approved by the local animal care committee
(Niedersaechsisches Landesamt fuer Verbraucherschutz und
Lebensmittelsicherheit) and were in compliance with the
guidelines for the welfare of experimental animals issued by
the European Communities Council Directive of 24 November
1986 (86/609/EEC) and the laws of the Federal Government
of Germany (Tierschutzgesetz; BGBl. I S. 1206, 1313 and BGBl.
I S. 1934).
To generate the Cx30.2lacZ mouse line, the coding region
of Cx30.2 was deleted and replaced with lacZ reporter DNA,
containing a nuclear localization signal, under the control of
the endogenous Cx30.2 promoter (Kreuzberg et al., 2006).
Cx36-deficient mice were generated as described (Deans et al.,
2002).
TABLE 1 | List of primary antibodies used in this study.
Antibody Antigen Host, type Dilution Source (Cat. No.)
Calbindin D-28K Recombinant rat calbindin D-28K Rabbit, polyclonal 1:500 Swant, Marly, Switzerland (CB-38)
Calretinin Guinea pig calretinin, full length amino acid
sequence
Goat, polyclonal 1:500 Merck-Millipore, Darmstadt,
Germany (AB 1550)
ChAT Human placental choline acetyltransferase Goat, polyclonal 1:250 Merck-Millipore (AB 144P)
Cx30.2 Peptide derived from amino acids 92–109 of
mouse Cx30.2
Guinea pig, polyclonal 1:500 Pineda Antibody Service, Berlin,
Germany
Cx30.2 Peptide derived from the last 20 amino acids
of the C-terminal end of mouse Cx30.2
Rabbit, polyclonal 1:5000 (wb) Pineda Antibody Service
1:500 (He)
Cx36 C-terminal region of rat and mouse Cx36,
derived from amino acids 286–303
Mouse, monoclonal 1:500 Invitrogen (37-4600)
Disabled-1 GST-mDisabled-1 fusion protein,
corresponding to amino acids 107–243
Rabbit, polyclonal 1:500 Gift from Dr B. Howell, NIH
β-Galactosidase Full length purified β-gal from Escherichia
coli
Chicken, polyclonal 1:500 Abcam, Cambridge, MA,
USA (ab9361)
GFP Full-length Aequorea victoria GFP Mouse, monoclonal 1:5000 Clontech, Mountain View, CA, USA
(632380)
Melanopsin 15 most N-terminal amino acids of the
mouse melanopsin extracellular domain
Rabbit, polyclonal 1:5000 Advanced Targeting Systems, San
Diego, CA, USA (AB-N38, UF006)
Parvalbumin Rat muscle parvalbumin Rabbit, polyclonal 1:5000 Swant (PV28)
Dilutions were identical for labeling of cryosections, retinal whole-mounts, Western blot (wb) and HeLa cell experiments (He) if not stated otherwise.
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Adult mice (aged 2–12 months) were euthanized with CO2
followed by cervical dislocation. Eyes were enucleated, and
cornea, lens and vitreous body were removed in 0.1 M phosphate
buffer (PB, pH 7.4) for immunohistochemical experiments.
For tracer-coupling experiments, injections were carried out in
Ringer’s solution (in mM: 110 NaCl, 2.5 KCl, 1 CaCl2, 1.6 MgCl2,
10 D-glucose, 22 NaHCO3) at room temperature, aerated with
95%O2 and 5% CO2 and resulting in an pH of 7.4 when reaching
the bath chamber. For dye injections in vibratome slices, the pH
of the Ringer’s solution was adjusted to 7.4 using 5 mM HEPES
instead of NaHCO3.
Intracellular Dye and Tracer Injections
For the dye injections of Cx30.2lacZ-positive cells, retinas
were isolated from the eyecup, bisected and embedded in
2% agar-agar in Ringer’s solution. Vertical vibratome sections
of 200 µm were prepared as described previously (Dedek
et al., 2006). The slices were stained with fluorescein-di-beta-
D-galactopyranoside (FDG; Sigma), a fluorogenic substrate
for β-galactosidase (β-gal) which can be used to visualize
lacZ-expressing cells. FDG was applied in Ringer’s solution
by adding 1.5 µl of a 120 mg/ml stock solution in dimethyl
sulfoxide (Sigma) to the bath chamber and washing it out with
the perfusion after 1–2 min. Labeled cells were injected under
visual control with sharp microelectrodes (120–180 M) filled
with 5 mM Alexa Fluor 488 potassium hydrazide (Invitrogen,
Karlsruhe, Germany) diluted in 0.2 M KCl, pH 7.4. Slices were
then fixed in 4% paraformaldehyde (PFA) and processed for
microscopy.
For tracer-coupling experiments, isolated retinae were cut
into halves or quarters and mounted, ganglion-cell side up, on
black nitrocellulose filters (Milipore, Billerica, MA, USA). AII
amacrine cells were injected either ‘‘blindly’’ by advancing the
electrode to the proximal inner nuclear layer (INL) and impaling
random cell somata, or under visual control after incubation
in 0.1 mM DAPI diluted in Ringer’s solution for 20–60 min
to visualize the nuclei of amacrine cells in the proximal INL.
Microelectrodes (120–180 M) were filled with 5 mM Alexa
Fluor 488 and 4% (w/v) neurobiotin (Vector Laboratories,
Burlingame, CA, USA). The Alexa dye was iontophoresed
with 0.5 nA square pulses of 500 ms at 1 Hz for 1–2 min
to visualize the cell’s morphology; when an AII cell was
successfully impaled, the current was reversed to inject the
positively charged neurobiotin (6–7 min). After the injection,
the tracer was allowed to diffuse for at least 15 min before
the specimen was fixed in 4% PFA for 10–20 min. We never
observed a systematic increase in AII cell tracer coupling
with longer diffusion times. The neurobiotin was visualized with
DyLight549-conjugated streptavidin (Jackson ImmunoResearch,
West Grove, PA, USA).
Immunostaining of Frozen Sections,
Whole-Mount Retinas and HeLa Cells
Eyecups were fixed in 4% PFA for 10 min, washed, cryoprotected
with 30% sucrose in 0.1 M phosphate buffer (PB, pH
7.4) overnight and embedded in TissueTek as described
(Dedek et al., 2009). Cryosections of 20 µm were cut, dried
and blocked with 5% ChemiBLOCKER (Millipore, Billerica,
MA, USA), 10% normal goat serum or donkey serum in PB.
Incubation with primary antibodies (Table 1) was carried out
at 4◦C overnight and, after extensive washing, with secondary
antibodies for 2 h at room temperature.
Whole-mount retinae were mounted on black filter paper,
fixed in 4% PFA for 10 min, washed and blocked with 10%
normal goat serum or donkey serum in PB. Primary antibodies
were incubated for 3–7 days at 4◦C, and secondary antibodies for
2–5 days at 4◦C. Formelanopsin immunolabeling, whole-mounts
were fixed overnight and incubations were carried out in 50 mM
TRIS buffer (pH 7.5) containing 1.5% NaCl, instead of PB.
For immunocytochemistry, 48 h after transfection, HeLa cells
were fixed on coverslips with 2% PFA for 15min. The subsequent
steps for immunolabeling were the same as for cryosections.
In all blocking and antibody incubation steps, the solutions
contained 0.3–0.5% Triton X-100 (and 0.05% NaN3 for
cryosections and retinal whole-mounts). Secondary antibodies
were conjugated to Alexa 488, Alexa 568 or Alexa 594 (1:500,
Invitrogen). For controls, the primary antibody was omitted;
occasional labeling of blood vessels was observed for secondary
anti-mouse antibodies. After final washes, all specimens were
mounted in Vectashield.
LacZ Staining in Retinal Cryosections
Vertical cryosections (20 µm) from Cx30.2lacZ/lacZ mice were
prepared as above and stained for β-gal activity as described
previously (Kranz et al., 2013). Briefly, slices were washed in lacZ
washing solution and incubated with the β-gal substrate X-gal for
1–7 days at 37◦C.
Electroretinogram Recording
Scotopic electroretinograms (ERGs) were recorded as described
previously (Kranz et al., 2013) from 10 mice of each genotype.
Full-field stimulation comprised 10 light intensities, ranging
from −3.5 to 1 log cds/m2. Data analysis was performed using
Chart v5.5 (AD Instruments, Hastings, UK). Data was evaluated
for statistical differences using two-way analysis of variance
(ANOVA) in Prism 5 (GraphPad Software, La Jolla, CA, USA).
Image Acquisition and Analysis
LacZ-stainings with X-gal (Figure 1C) were imaged on a
Zeiss Axiophot 2 equipped with a 63× plan Apochromat oil
immersion objective (NA 1.4) and a Zeiss AxiocamMRc. Z-series
were taken at manually chosen focal planes. In order to detect
even very faint X-gal signals and to distinguish them from small
debris particles, the blue X-gal signals (which maximally absorb
in the red spectrum of visible light) were extracted in ImageJ
(NIH, Bethesda, MD, USA) by generating minimum projections
of the image stacks, splitting the RGB images into separate
channels and generating difference images of the red and the blue
channel (Figure 1D).
Intracellular dye injections into FDG-labeled cells in
vibratome slices (Figures 3A,B) were documented during the
injections on a Zeiss Axioskop equipped with a 40 × Achroplan
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FIGURE 1 | Reporter gene expression in the Cx30.2lacZ/lacZ retina is confined to the ganglion cell layer (GCL) and the proximal inner nuclear layer
(INL). (A) Successful deletion of Cx30.2 was confirmed by RT-PCR. The Cx30.2-specific transcript was only detected in Cx30.2+/+ and not in Cx30.2lacZ/lacZ mice.
Intron-spanning actin primers were used to prove that samples were not contaminated by genomic DNA: only the 573 bp for cDNA is visible whereas the 1027 bp
for genomic DNA was not detected. (B) Immunofluorescence staining for β-galactosidase (β-gal) in a vertical section of the Cx30.2lacZ/lacZ retina. The inset on the left
is a transmission image of the same area indicating the layers of the retina (ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner
plexiform layer; GCL, ganglion cell layer). In the INL, immunoreactive cells are visible right at the border between INL and IPL (arrows) or a bit more distal (arrowhead).
(C) X-gal staining of a Cx30.2lacZ/lacZ retina. Blue signals indicate β-gal expression. (D) Same image as in (C) showing the extracted signals of the X-gal staining
along a Z-series and confirming the exclusive expression in the GCL and the proximal INL. (E,F) Whole-mount stainings for β-gal (E1,F1) and choline
acetyltransferase (ChAT, E2,F2) in the INL (E) and GCL (F) to quantify β-gal expression. ChAT signals never colocalized with β-gal signals. (G) Schematic of a
whole-mount retina indicating the approximate locations for quantification. (H) Quantification of β-gal expressing cells depending on the eccentricity within the retina
(mean ± SD, n = 8 central-to-peripheral axes). Scale bars: (B,E,F) 50 µm; (C,D) 20 µm; (G) 1 mm.
water immersion objective (NA 0.75) and a Leica DFC320
camera. These RGB photomicrographs were converted to 8-bit,
recolored and aligned with confocal images using ImageJ.
Confocal images of retinal sections and whole-mounts were
taken on Leica SP2 or SP8 TCS SL microscopes with a 40×HCX
PL APO oil immersion objective (NA 1.25 or 1.3). For HeLa
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cells, a 63× HCX PL APO oil immersion objective (NA 1.32)
was used.
For the quantification of β-gal-positive cells (Figures 1G,H),
confocal stacks comprising the ganglion cell layer (GCL), inner
plexiform layer (IPL) and INLwere taken along the dorso-ventral
and naso-temporal axes of the retina at intervals of 350 µm. At
each location, a square area of 200 × 200 µm was evaluated.
Cells were counted manually in maximum projections of partial
confocal stacks using the cell counter plugin of ImageJ. If in
doubt, the original stacks were re-examined. As proposed by Jeon
et al. (1998), choline acetyltransferase (ChAT)-immunoreactive
cells were also counted and used as a standard. Our average
numbers of ChAT-positive cells deviate from the published
numbers by less than 4% (INL: −1.3%, GCL: −3.7%). Since we
did not observe obvious differences between the major axes of
the retina, all data are presented as mean ± standard deviation
of the mean (SD) as a function of eccentricity. Colocalization of
β-gal-immunoreactivity with different calcium-binding proteins
(CaBPs, Figure 2, Table 2) was evaluated in a similar way
in randomly chosen mid-peripheral locations (n = 2–4 scans
from 2 to 4 retinae). For the density of Cx36-immunoreactive
clusters in wild-type and Cx30.2lacZ/lacZ retinae (Figure 6J),
confocal stacks were taken in four retina pieces obtained from
three animals per genotype, deconvolved with a theoretical point
spread function using Huygens Essential deconvolution software
(SVI, Hilversum, Netherlands) and processed afterwards with
Fiji (http://fiji.sc/Fiji; Schindelin et al., 2012). Sixty-four regions
of interest (four per image; 22,900 µm2 in total per genotype and
sublayer) were positioned randomly in the middle of the ON-
and OFF-sublayers of the IPL and then shifted to the nearest
place that did not contain any blood vessels, if necessary.
After segmentation (Li’s threshold) and separation of fused
particles using the watershed algorithm, clusters were counted
automatically.
To quantify the size of gap junctional clusters between
adjacent HeLa cells, confocal stacks were deconvolved
with a theoretical point spread function using Huygens
Essential and processed afterwards with Fiji. Stacks were
normalized to the respective stack histogram and segmented
automatically (Otsu’s threshold). The 3D Simple Segmentation
algorithm was used for the automatic detection of gap
junction clusters, which were then measured in volume
using the 3D Manager (Fiji plugin). For each combination of
plasmids, the number and size of clusters were determined
for three independent transfection experiments. Data were
evaluated for statistical differences using the Kruskal-
Wallis test in Prism, with adjusted p-values for multiple
comparisons.
All images were adjusted in brightness and contrast
for presentation purposes using ImageJ or Fiji. Confocal
micrographs are presented as maximum or average projections
of the image stacks, except for the rotated projections in
Figures 6C,F which are 3D-projections. HeLa cell stainings are
represented as maximum projections of three subsequent scans.
Some confocal images of nuclear or somatic immunostainings
were filtered with a Gaussian (r = 2 pixels) prior to projection
in order to reduce noise.
RESULTS
LacZ Expression in Cx30.2-Deficient Mice
To study the expression of Cx30.2 in the mouse retina,
we used a mouse line in which the coding region of
Cx30.2 was replaced by lacZ reporter DNA (Kreuzberg et al.,
2006; Müller et al., 2010a), coding for β-gal. Successful
deletion of Cx30.2 from the mouse retina was confirmed
by RT-PCR (Figure 1A): the Cx30.2-specific band (422 bp)
was only detected in wild-type and not in Cx30.2-deficient
retina. Contamination by genomic DNA was excluded using
intron-spanning actin primers. Labeling retina sections with
anti-β-gal antibodies revealed lacZ expression exclusively in the
proximal INL and the GCL (Figure 1B). LacZ staining with
the non-fluorogenic substrate X-gal showed precipitates in the
same layers (Figures 1C,D), suggesting Cx30.2 expression in
amacrine and ganglion cells only. Consistent with an earlier
study (Müller et al., 2010a), staining for β-gal and X-gal
indicated Cx30.2 expression in at least two different populations
of amacrine cells: one population with the soma at the
border between INL and inner IPL (Figure 1B, arrows) and
a second, with fewer positive cells, more distally (Figure 1B,
arrowhead). Likewise, several different populations of neurons
were labeled in the GCL as discernible by the different
sizes of labeled somata (Figures 1B–D). β-gal expression was
similar in heterozygous and homozygous Cx30.2lacZ mice. We
never detected lacZ-expressing cells in the distal INL (bipolar
or horizontal cells) or in photoreceptors. In contrast to an earlier
study (Manasson et al., 2013), we did not find any indication
for Cx30.2 expression in endothelial cells in the mouse retina:
lacZ-expressing nuclei never showed the typical elongated shape
of endothelial nuclei and were never observed in areas with
retinal blood vessels.
To estimate the density of lacZ-expressing cells, we labeled
whole-mount retinas for ChAT (Figures 1E–H). ChAT is a
marker for starburst amacrine cells which form two almost
identical populations of amacrine cells, whose cell bodies are
located in the INL and GCL. As starburst cell density is well
known—they make up 3% of all amacrine cells in the INL and
11.5% of all cells in the GCL (Jeon et al., 1998)—we used them
as a reference population. LacZ-positive cells in the INL showed
a much higher density than starburst amacrines (Figure 1H;
∼4800 vs. 1500 cells/mm2 at 500 µm eccentricity); we never
found lacZ expression in ChAT-labeled cells. Using starbursts
as a reference, we estimated that 9% of all amacrine cells in the
INL express Cx30.2. The relatively high density confirms the
presence of several lacZ-positive populations in the INL. This
supports an expression in narrow-field amacrine cells because
these amacrines show high densities to allow full coverage of the
retina.
The density of lacZ-expressing somata in the GCL was also
higher than the number of ChAT-expressing starburst cells,
in line with our previous results that several populations of
ganglion cells express Cx30.2 (Müller et al., 2010a). Assuming
that Cx30.2-expressing cells in the GCL comprise no or very few
displaced amacrine cells (Müller et al., 2010a), the average of 1886
cells/mm2 in the GCL adds up to about 54% of all ganglion cells.
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FIGURE 2 | Cx30.2lacZ-expressing neurons belong to several different populations of amacrine and ganglion cells, including intrinsically
photosensitive retinal ganglion cells (ipRGCs). (A–H) Double immunofluorescence stainings for β-gal (A1–H1) and calbindin (A2,B2), calretinin (C2,D2),
parvalbumin (E2,F2), and melanopsin (G2,H2) in the INL (A/C/E/G) and GCL (B,D,F,H) of Cx30.2lacZ/lacZ whole-mount retinae. (A3–H3) show overlays of the
respective single channels. Arrows indicate example cells that express both antigens, double arrows indicate cells that express β-gal but lack the respective marker,
and arrowheads indicate cells expressing the marker but lacking β-gal. Insets in (G1) show intensity-enhanced magnifications of the areas marked by dashed
squares to verify colocalization with melanopsin. Scale bar: 50 µm.
To further characterize lacZ-positive cells, we labeled whole-
mount retinas for β-gal and either calbindin (Figures 2A,B),
calretinin (Figures 2C,D) or parvalbumin (Figures 2E,F), which
are all markers for amacrine and ganglion cells (Haverkamp and
Wässle, 2000). In the INL, we did not find colocalizaton of β-gal
with calretinin (Figure 2C) but a high degree of overlap with
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TABLE 2 | Colocalization (coloc.) of β-galactosidase immunoreactivity with different calcium-binding proteins (CaBP).
(n) CaBP-positive β-gal-positive coloc. %-coloc. %-coloc.
cells cells (β-gal/CaBP) (CaBP/β-gal)
INL
Calretinin 2 99 ± 11 243 ± 69 1 0.5 0.2
Parvalbumin 4 329 ± 52 308 ± 64 59 ± 13 18 ± 3 19 ± 1
Calbindin 4 432 ± 76 293 ± 38 169 ± 33 40 ± 9 57 ± 6
GCL
Calretinin 3 191 ± 38 125 ± 39 72 ± 19 38 ± 10 59 ± 11
Parvalbumin 4 149 ± 16 174 ± 24 63 ± 9 42 ± 5 37 ± 6
Calbindin 4 193 ± 55 149 ± 20 44 ± 27 21 ± 7 29 ± 16
(n) is the number of retinae; a square area of 300 × 300 µm2 was evaluated in each retina. All values are given as mean ± standard deviation.
calbindin-positive (Figure 2A) and parvalbumin-positive somata
(Figure 2E; please see Table 2 for numbers). The majority of
cells positive for β-gal and calbindin or parvalbumin most likely
represented amacrine cells (Figures 2A,E) because of their high
density and small somata. However, some parvalbumin- and
β-gal-positive somata in the INL were very large and most likely
represented displaced ganglion cells (Figure 2E). We found two
different examples of displaced ganglion cells which expressed
either both antigens or only one of the two.
In the GCL, all three markers showed considerable
colocalization with β-gal (Figure 2; Table 2). As calretinin
and parvalbumin were reported to demonstrate a differential
expression among different types of ganglion cells (Kim and
Jeon, 2006; Lee et al., 2010), these data again confirm Cx30.2
expression in several populations of ganglion cells.
Taken together, we find Cx30.2 expression restricted to the
INL and GCL, in a variety of amacrine and ganglion cell types.
LacZ Expression in Melanopsin-Positive
Ganglion Cells
In an earlier study, we identified Cx30.2 expression in six
different types of ganglion cells (Müller et al., 2010a), in
which Cx30.2 may contribute to homotypic coupling among
ganglion cells of the same type or to heterotypic coupling to
amacrine cells. Heterotypic coupling has also been demonstrated
for intrinsically photosensitive retinal ganglion cells (ipRGCs):
three subtypes of ipRGCs (M1–M3) were shown to be tracer-
coupled to displaced amacrine cells (Müller et al., 2010b); and
recently, Reifler et al. (2015) reported that ipRGCs provide
input to displaced, spiking ON amacrine cells via electrical
synapses. As the gap junction protein expressed by ipRGCs is
not known, we double-labeled Cx30.2lacZ/lacZ retinas for β-gal
and melanopsin (Figures 2G,H), the photopigment expressed
by ipRGCs. Indeed, we found strong colocalization of both
signals in large somata in the GCL (Figure 2H) and in ipRGCs
displaced to the INL. However, some melanopsin-positive
somata displayed very weak or no β-gal immunoreactivity,
suggesting that not all ipRGCs express Cx30.2 (Figure 2H,
arrowhead).
In summary, we identified Cx30.2 as a strong candidate
for forming the gap junctions between ipRGCs and displaced
amacrine cells.
LacZ Expression in AII Amacrine Cells
The high density of lacZ-expressing neurons in the INL suggested
Cx30.2 expression in narrow-field amacrine cells of which the
mouse retina contains at least 13 different types (Pang et al.,
2012; Lee et al., 2015). As specific markers are only available
for some of these types, we took a different approach to
further characterize Cx30.2-expressing cells in the INL. We
used a fluorogenic substrate of β-gal to label lacZ-positive
cells in retina vibratome sections (Figures 3A,B). Pre-labeled
somata were subsequently targeted with an Alexa dye-filled
microelectrode (Figure 3A1,2) and images were first taken in the
living tissue and, after fixation, cell identity was confirmed with
confocal microscopy (Figure 3B). These experiments revealed
the morphology of lacZ-expressing amacrine cells: (1) the
cells’ somata were located right at the border between INL
and IPL; and (2) cells had a thick primary dendrite which
(3) branched into lobular appendages in the OFF sublamina and
fine, arboreal processes, crossing the entire ON sublamina of the
IPL. This morphology is typical for AII amacrine cells (Hartveit
and Veruki, 2012) and was observed for all reliably injected
amacrine cells (n = 12). To confirm this finding, we labeled
retina cryosections for β-gal and disabled-1 (Figures 3C–E),
a marker for AII amacrine cells in the mouse retina (Rice
and Curran, 2000). Most cell somata labeled for disabled-
1 were also positive for β-gal (Figure 3, arrows). However,
some AII cells lacked β-gal immunoreactivity (Figures 3C–E,
double arrow). Likewise, some β-gal-positive somata between
the AII cells or located more distally from the INL/IPL
border lacked disabled-1 immunoreactivity (Figures 3C–E,
arrowheads).
In summary, these data provide evidence that AII amacrine
cells, known to couple via Cx36, additionally express Cx30.2,
which is also made by other—yet unidentified—amacrine cell
types.
Characterization of Anti-Cx30.2 Antibodies
Although the vast majority (94%) of Cx30.2-expressing,
parvalbumin-positive interneurons in the hippocampus also
expresses Cx36 (Kreuzberg et al., 2008), interaction of Cx30.2
and Cx36 has never been shown. In contrast, Cx36 was assumed
to only form homomeric connexons (Teubner et al., 2000;
Li et al., 2008). Therefore, we aimed to investigate whether
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FIGURE 3 | Cx30.2lacZ-expression in AII amacrine cells. (A) Ex vivo
labeling of Cx30.2lacZ-expressing cells in a vibratome slice of a Cx30.2lacZ/lacZ
retina using fluorescein-di-β-D-galactopyranoside (FDG). Arrows indicate cells
(A1,A2) that were chosen for the intracellular injection of Alexa 488. Insets
(A1,A2) document the intracellular injection; the injection electrode is visible on
the left side of the images. Arrowheads in (A) indicate morphological features
of the injected cells that help confirming the successful impalement of the
targeted cells. (B) Confocal micrograph showing the typical AII morphology of
the injected cells from (A) with lobular appendages in the distal IPL and
arboreal dendrites in the proximal INL. (C–E) Double labeling for β-gal (C) and
the AII marker disabled-1 (D) verifies the Cx30.2lacZ-expression in most AII
amacrine cells (E, arrows). Some AII cells, however, display very little or no
Cx30.2lacZ-expression (double arrow); also, few non-AII amacrine cells are
positive for β-gal (arrowheads). Scale bars: (A–D) 20 µm; (E) 50 µm.
Cx30.2 and Cx36 are able to interact and form heteromeric
gap junctions. As commercially available antibodies give the
same staining in wild-type and Cx30.2 lacZ retina (Müller
et al., 2010a), we generated polyclonal antibodies in rabbits,
using a peptide derived from the last 20 amino acids of the
C-terminal end of mouse Cx30.2. This peptide shows no
sequence homology with other connexin isoforms. Specificity
of the affinity-purified antibodies was evaluated on HeLa
cells, transfected with different connexin constructs: Cx36
and Cx30.2, expressed either alone or in combination with
Cx36-EGFP and Cx30.2-EGFP fusion proteins (Figure 4A).
Western blot analysis of HeLa cell extracts revealed bands of
32–36 kDa for Cx30.2 and 58 kDa for Cx30.2-EGFP fusion
proteins when blots were probed with our newly generated
anti-Cx30.2 antibodies (Figure 4A, bottom). The native Cx30.2
showed several immunoreactive bands in the range of 32–36 kDa
(Figure 4A, bottom, open arrowhead), slightly higher than the
expected size of 30 kDa, suggesting different phosphorylation
states. Treatment with alkaline phosphatase proved that these
bands are indeed due to phosphorylation (Supplementary Figure
1). Probing the same blots with anti-EGFP antibodies verified
the specificity of Cx30.2-immunoreactive signals (Figure 4A,
lanes 4, 6). Notably, EGFP-positive bands occurred at a higher
molecular weight for Cx30.2-EGFP constructs than Cx36-EGFP
constructs, pointing to differences in phosphorylation states
(Figure 4A, filled arrowheads, top). Cross-reactivity with Cx36
was excluded because anti-Cx30.2 antibodies did not recognize
Cx36 in Cx36-transfected HeLa cell extracts (Supplementary
Figure 2A).
Antibody specificity was also tested in immunostainings of
HeLa cells (Figure 5) transfected with Cx30.2-EGFP alone. The
native EGFP and antibodies directed against Cx30.2 showed the
same pattern and almost complete overlap of both signals, again
verifying the specificity of the Cx30.2 antibodies (Figure 5B).
Untransfected cells were void of labeling (see Supplementary
Figure 2A).
As rabbit anti-Cx30.2 antibodies did not work in tissue
(see next paragraph), we also generated anti-Cx30.2 antibodies
in guinea pig against amino acids 92–109 of the cytoplasmic
loop (Table 1). Compared to the rabbit antibodies, guinea pig
antibodies gave similar results in Western Blot and HeLa cell
experiments (Supplementary Figure 3). Although the peptide
showed 50% identity with mouse Cx36, no cross-reactivity with
Cx36 was observed (Supplementary Figure 3).
Interaction of Cx30.2 and Cx36
Unfortunately, none of our anti-Cx30.2 antibodies worked
on mouse cryosections although different tissues (heart,
retina, brain) were tested with different fixation and
incubation protocols (4% vs. 2% PFA, PBS, PB, TBS with
or without triton-X100 etc.) and different epitope unmasking
techniques (heat and citrate buffer). It is possible that the
immunogenic regions contain phosphorylation sites or may
be complexed with other proteins. This prevented us from
directly examining the co-expression and potential interaction
of both connexins in AII amacrine cells and other brain
areas.
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FIGURE 4 | Newly generated anti-Cx30.2 antibodies (rabbit) are specific and reveal interaction of Cx30.2 and Cx36. (A) Western blot analysis of HeLa cell
extracts transfected with different combinations of Cx30.2 and Cx36 and their enhanced green fluorescent protein (EGFP)-tagged variants. Blots were probed with
anti-GFP, anti-Cx36 and newly generated anti-Cx30.2 antibodies from rabbit. Anti-Cx36 and anti-Cx30.2 antibodies recognize the respective connexin (A,B, open
arrowheads) and its fusion variant (A,B, filled arrowheads). Please note that several bands become visible for untagged Cx30.2, pointing to different phosphorylation
states (also see Supplementary Figure 1). These bands are not visible for the fusion protein. The Cx36 signal (lane 5) is extremely weak and nearly not visible but
becomes apparent after immunoprecipitation (IP; B, lane 5). (B) IP using the same HeLa cell transfections as in (A). Single or double transfections with untagged
connexins did not show any bands in IP, as expected (lanes 1, 3, 9). Most importantly, when cells expressed Cx36-EGFP and untagged Cx30.2, Cx30.2 was
detected in the IP (lane 7, lowest blot, open arrowhead); similarly, when cells expressed the Cx30.2-EGFP fusion protein together with Cx36, a band appeared for the
native Cx36 (lane 8, middle blot, open arrowhead). These results suggest interaction of Cx30.2 and Cx36 in HeLa cells. Please note that the anti-Cx36 antibody
produced several unspecific bands. The strong band at 25 kDa (B) presumably originates from the light chain of the GFP antibody from the magneto-beads, reacting
with the secondary antibody. The origin of the strong double band appearing in lane 8 (B) is unclear. For detection with anti-Cx30.2 (A,B), the same blot was used as
for Cx36 after stripping.
However, to test whether Cx30.2 and Cx36 can principally
interact, we performed co-IP experiments. HeLa cells were
transfected either with Cx30.2, Cx36, Cx30.2-EGFP and
Cx36-EGFP alone or, as double transfection, in all possible
combinations (except for Cx30.2-EGFP with Cx36-EGFP;
see Figure 4) to control for effects of the EGFP tags (Helbig
et al., 2010). GFP antibodies coupled to magnetic beads
were used to isolate GFP-containing connexins from HeLa
cell extracts. As expected, non-tagged connexin variants
(lanes 1, 3, 9) were detected with the respective anti-Cx
antibodies in extracts (Figure 4A, open arrowheads) but not
in immunoprecipitates (Figure 4B), whereas the single fusion
proteins showed bands in extracts and immunoprecipitates
(Figures 4A,B, filled arrowheads, lanes 2, 4), with the
Cx36-EGFP band running slightly lower than the expected
64 kDa. Moreover, when HeLa cells were transfected
with equal amounts of the tagged and untagged connexin
variant (Cx30.2 + Cx30.2-EGFP and Cx36 + Cx36-EGFP,
lanes 5 and 6, respectively), both proteins were detected
after IP (Figure 4B)—as expected when both variants are
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FIGURE 5 | Cx30.2 and Cx36 can assemble into the same gap junctional plaques in HeLa cells. HeLa cells transfected with Cx30.2 (A), Cx30.2-EGFP
(B), Cx30.2 + Cx30.2-EGFP (C), Cx36 (D), Cx30.2 + Cx36 (E) and Cx30.2-EGFP + Cx36 (F). For Cx30.2 detection, our newly generated rabbit antibodies were
used. Cx30.2 and Cx36 appear in the same gap junctional plaques when co-expressed (E,F). Please note the size differences for the different transfections. Gap
junction plaques containing only variants of Cx30.2 (A–C) were rather small compared to gap junction plaques containing the native Cx36 and Cx30.2 variants
(D–F). Controls with tagged and untagged Cx variants served to control for effects of the EGFP tag (as shown by Helbig et al., 2010 for Cx36-EGFP). Arrowheads
point to gap junction plaques between two adjacent HeLa cells. (G) Boxplots representing the volume of gap junction clusters in the different HeLa cell transfections,
determined with antibodies for Cx30.2, EGFP and Cx36. Red crosses represent outliers. Please note that the two detection channels in individual transfections were
never significantly different (p > 0.999). n = 38–58 gap junction clusters from three different transfection assays. ∗p < 0.05; ∗∗∗∗p < 0.0001. Scale bar: 20 µm.
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inserted into the same gap junction channel, demonstrating
the reliability of the IP protocol. Most importantly, when HeLa
cells expressed Cx36-EGFP together with Cx30.2, Cx30.2 was
immunoprecipitated together with the EGFP-tagged Cx36
construct (Figure 4B, lane 7). Conversely, Cx36 was pulled
down via Cx30.2-EGFP when cells co-expressed both constructs
(Figure 4B, lane 8).
To exclude that the interaction of Cx30.2 and Cx36 only
occurred via the GFP tag, we performed IP experiments with the
untagged proteins expressed in HeLa cells (Supplementary
Figure 4). When Cx30.2 and Cx36 were co-expressed,
Cx36 was pulled down with Cx30.2 antibodies coupled
to beads (Supplementary Figure 4, asterisk). When HeLa
cells were only transfected with Cx36, the pull-down was
negative, as expected for this control condition. In summary,
these results demonstrate that Cx36 and Cx30.2 are able
to interact and presumably form heteromeric channels in
HeLa cells.
To confirm these results, we analyzed the same combinations
of constructs as used for co-IP with immunolabeling of HeLa
cells (Figure 5), in three independent transfection experiments.
In transfections with only Cx30.2 variants (Figures 5A–C,
arrowheads), gap junction plaques were rather small, did not
differ in size for EGFP-tagged and untagged Cx30.2 but were
significantly smaller than when Cx36 was expressed alone
(Figures 5D,G). When Cx30.2 variants were co-expressed
with Cx36 (Figures 5E,F, arrowheads), Cx30.2-containing gap
junction plaques became significantly larger (Figure 5G) when
compared to Cx30.2 variants alone. This indicates that Cx30.2 is
incorporated into the larger gap junction plaques made of Cx36.
Together with the complete overlap of both immunosignals, this
again suggests interaction of Cx36 and Cx30.2; however, other
explanations cannot be excluded. The volume occupied by the
immunoreactivities for Cx36 and Cx30.2 was the same when
Cx36 and Cx30.2 were co-expressed (Figure 5F; p > 0.999),
suggesting the formation of heteromeric gap junction channels.
Naturally, we cannot exclude the formation of heterotypic
gap junction channels with Cx36-containing hemichannels
provided by one cell and Cx30.2-containing hemichannels
by the other. However, immunosignals for Cx36 and Cx30.2
variants do not only overlap in the plasma membrane, at
the gap junction plaque, but also in intracellular vesicles
which presumably transport individual connexin hemichannels
to the membrane. Thus, we hypothesize the formation of
heteromeric rather than heterotypic Cx36/Cx30.2 gap junction
channels.
In summary, we provide the first biochemical evidence that
Cx30.2 can interact with Cx36 and presumably form heteromeric
gap junctions.
Assessing the Primary Rod Pathway in
Cx30.2-Deficient Mice
As we found Cx30.2 expression in AII amacrine cells of the
mouse retina and HeLa cell experiments suggest the formation
of heteromeric Cx36/Cx30.2 gap junction channels, we aimed
to analyze the effects of Cx30.2-deficiency on the primary rod
pathway. AII amacrine cells form two different sets of gap
junctions, both of which we tested for functionality. To assess
signal transmission from AII amacrine cells via heterocellular
gap junctions to ON cone bipolar cells, we recorded scotopic
ERGs (Figures 6A,B). If these junctions were affected by the
lack of Cx30.2, the b-wave amplitude, reflecting the summed
potential of depolarizing (ON) bipolar cells in response to a
brief flash of light, should be reduced, as was reported for Cx36-
and Cx45-deficient retinas (Güldenagel et al., 2001; Maxeiner
et al., 2005). However, scotopic ERGs were unaffected: a- and
b-wave amplitudes were the same for Cx30.2-expressing and
-deficient mice (Figure 6B). These data suggest that AII/ON cone
bipolar cell gap junctions are completely functional in Cx30.2-
deficient mice.
Next, we injected the gap junction-permeant tracer
neurobiotin into individual AII amacrine cells and compared
tracer spread between genotypes. Again, we found no significant
differences: AII amacrine cells were coupled on average to six
other AII amacrine cells and 12 ON bipolar cells under our
injection conditions (Figures 6C–I), whereas coupling to both
cell types was completely abolished when Cx36 was knocked out
(Figure 6I). These data indicate that also AII/AII gap junctions
are functional in Cx30.2-deficient mice.
To test whether lack of Cx30.2 was compensated by
upregulation of Cx36, we quantified Cx36 immunoreactivity in
the ON and OFF sublamina of the IPL in controls and Cx30.2-
deficient mice. However, again no significant differences were
found between genotypes (Figures 6J–L).
Taken together, these data suggest that Cx30.2 only plays a
minor role in the primary rod pathway. However, it may serve
a regulatory function or represent a substrate for the observed
differences between homo- and heterocellular gap junctions
made by AII amacrine cells.
DISCUSSION
This study provides, to the best of our knowledge, the first
biochemical demonstration that Cx30.2 is able to interact
with Cx36 in HeLa cells. Moreover, we find Cx30.2 to
be expressed in AII amacrine cells and ipRGCs in the
mouse retina. Despite its expression in AII cells, the relay
interneurons of the primary rod pathway, scotopic ERGs were
not impaired and tracer coupling of AII cells was unaltered
in Cx30.2-deficient mice. We hypothesize that Cx30.2 may
rather have a regulatory function for Cx36-containing gap
junctions in AII cells than being important for rod signal
transmission.
Potential Heteromerization of Cx30.2
and Cx36
In the mouse brain, the expression profiles of Cx36 and Cx30.2
are similar, with a high degree of co-expression in striatum,
hippocampus and cortex (Kreuzberg et al., 2008). Both connexins
are also found in β-cells of the pancreas (Coronel-Cruz et al.,
2013) and chromaffin cells of the adrenal medulla (Kreuzberg
et al., 2008). Despite the extensive co-distribution of the two
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FIGURE 6 | In Cx30.2lacZ/lacZ mice, the primary rod pathway is unaffected from lack of Cx30.2. (A,B) Electroretinograms under scotopic conditions did not
differ between Cx30.2lacZ/lacZ mice and their wild-type littermates. The amplitudes of a- and b-wave did not show any significant differences. (C–H) Representative
results of AII cell tracer-coupling experiments (asterisks represent Alexa-Fluor-488-injected AII cells; the tracer neurobiotin is shown in magenta). Rotated projections
show the injected AII amacrine cell (asterisk) and neurobiotin-containing coupled cells (C,F). Whole-mount views of an AII amacrine cell (asterisk) with its
tracer-coupled partners in the proximal and distal INL, representing AII (D,G) and ON cone bipolar cells (E,H), respectively. (I) The amount of tracer coupling of AII
amacrine cells did not differ between Cx30.2-deficient and wild-type mice. In contrast, coupling to both AII amacrine and ON cone bipolar cells was completely
abolished when Cx36 was knocked out. (J–L) Lack of Cx30.2 was not compensated by upregulation of Cx36 in the OFF (K1,L1) or ON sublamina of the IPL (K2,L2).
The number of Cx36-positive clusters did not differ between genotypes. Scale bars: (C–H) 20 µm; (K,L) 10 µm.
connexins, none of the previous studies examined whether they
could form heteromeric Cx30.2/Cx36 gap junction channels.
In contrast, Cx36 was assumed to only form homomeric and
homotypic gap junction channels (Teubner et al., 2000; Li et al.,
2008) whereas Cx30.2 was shown to form heteromeric channels
with other cardiac connexins (Gemel et al., 2008).
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Using newly generated anti-Cx30.2 antibodies, we
demonstrate that Cx30.2 can assemble with Cx36 into gap
junction channels in HeLa cells. Evidence comes from
three independent sets of transfection experiments in HeLa
cells: (1) (co)-IP with EGFP-tagged connexins via anti-EGFP
antibodies coupled tomagnetobeads; (2) (co)-IP of Cx36 via anti-
Cx30.2 antibodies coupled to beads; and (3) immunofluorescence
quantification of gap junction plaque size. IP of Cx36-EGFP led
to pull-down of Cx30.2 when both connexins were co-expressed.
Conversely, Cx36 was pulled down when co-expressed with
Cx30.2-EGFP. We excluded that the interaction is only indirect
via the GFP tag by demonstrating pull-down of Cx36 upon
co-expression with Cx30.2. Additionally, we quantified the size
of gap junction plaques formed in HeLa cells transfected with
Cx30.2 variants alone and in co-expression with Cx36. Gap
junction plaques containing Cx30.2 (or its EGFP-tagged variant)
alone were significantly smaller in volume than when Cx36 was
co-expressed. Moreover, as expected for heteromeric channels,
both connexins occupied the same volume when co-expressed
(p> 0.999).
We cannot entirely exclude, however, that Cx30.2 and
Cx36 form bi-homotypic gap junctions, as is debated for
Cx45 and Cx36 in the retina (Li et al., 2008). In this case,
a protein binding to Cx30.2 and Cx36 would co-scaffold
both connexins and thus promote the formation of larger
Cx30.2 homotypic gap junction plaques when Cx36 and Cx30.2
are co-expressed. However, bi-homotypic Cx30.2 and Cx36
intercellular channels would colocalize and occupy the same
volume only if the affinity of the scaffolding protein for
both connexins is exactly the same. Thus, the presence of
bi-homotypic Cx30.2 and Cx36 gap junctions seems highly
unlikely.
Together, these data provide evidence for interaction of
Cx36 and Cx30.2 in HeLa cells and suggest the formation of
heteromeric channels.
Cx30.2-Expressing Cell Types
In the mammalian retina, expression of Cx30.2 was shown
in six different types of ganglion cells and so far undefined
groups of amacrine cells (Müller et al., 2010a). Here, we
further characterized Cx30.2-expressing neurons in the mouse
retina, using lacZ expression in Cx30.2lacZ mice as a proxy.
This is a feasible approach because earlier studies from
Kreuzberg et al. (2006) and Müller et al. (2010a) also
used lacZ labeling to identify Cx30.2-expressing cells and
confirmed Cx30.2 expression functionally as a slowing of
conductance velocity in the heart and loss of tracer coupling
in retinal ganglion cells in Cx30.2-deficient mice, respectively.
As we could not directly reveal the Cx30.2 protein, we
confirmed Cx30.2 expression by RT-PCR from wild-type retinas
(Figure 1A).
LacZ-expressing cells were numerous in the proximal
INL and the GCL. They showed a high degree of co-
expression with the calcium-binding proteins parvalbumin and
calbindin in both layers and calretinin in the GCL, consistent
with Cx30.2 expression in multiple types of amacrine and
ganglion cells. Pang et al. (2013) recently demonstrated that
heterotypic amacrine/ganglion cell coupling is not completely
abolished in Cx36/Cx45-deficient mice. Therefore, it seems
likely that Cx30.2 electrically couples amacrine and ganglion
cells, which we also demonstrated earlier for RGA1 ganglion
cells (Müller et al., 2010a). However, the functional role of
the coupling between diverse types of amacrine and ganglion
cells is still largely unknown (see also below, Pang et al.,
2013).
Cx30.2 is Expressed in Intrinsically
Photosensitive Ganglion Cells (ipRGCs)
ipRGCs express the photopigment melanopsin and were
shown to mediate non-image-forming visual functions, such as
pupillary constriction and circadian photoentrainment (Güler
et al., 2008). The mouse retina contains five different types
of ipRGCs (M1–5; Sand et al., 2012), with types M1–3
immunoreactive to melanopsin. Calcium imaging showed that
ipRGCs form networks that could be uncoupled by the
gap junction blocker carbenoxolone (Sekaran et al., 2003).
The presence of gap junctions on ipRGCs was later verified
by tracer injections: types M1–3 show tracer coupling to
GABAergic, displaced wide-field amacrine cells (Müller et al.,
2010b) and Cx30.2 was suggested as the underlying connexin.
Our data support this suggestion because double labeling for
β-gal and melanopsin demonstrated a high degree of co-
expression in ganglion cells in the INL and GCL. As most
ganglion cells are coupled via Cx36 (Pan et al., 2010), it
seems possible that Cx36 and Cx30.2 are both expressed in
some ipRGCs. However, M2 ganglion cells were proposed
to lack Cx36 (Pan et al., 2010) and correspond to RGA1
cells (Sun et al., 2002) which were earlier described to be
coupled to two different types of polyaxonal amacrine cells
(Völgyi et al., 2009). Using tracer injections, we showed before
Müller et al. (2010a) that RGA1 (M2) cells lose their coupling
when Cx30.2 is missing, suggesting that M2 cells form gap
junctions containing only Cx30.2 on the M2 cell side. M3
cells which were also shown to be coupled to displaced
amacrine cells are bistratified neurons (Müller et al., 2010b).
As these ipRGCs are also immunoreactive to melanopsin
it is likely that they also express Cx30.2 because of the
strong co-expression of Cx30.2 and melanopsin. Interestingly,
Cx45 was found to be expressed in bistratified ganglion cells
(Schubert et al., 2005) raising the possibility that Cx30.2 and
Cx45 are co-expressed. As Cx45 was shown to be able to
heteromerize with Cx30.2 (Gemel et al., 2008), interaction
with Cx45 could also be a potential function of Cx30.2 in
ipRGCs.
Coupling between amacrine and ganglion cells was generally
considered to enlarge receptive fields and synchronize firing
of ganglion cells. However, Reifler et al. (2015) recently
showed that ipRGCs do not receive input from but instead
provide input to displaced amacrine cells via gap junctions.
Thus, Cx30.2 may serve to propagate the sustained light
responses from ipRGCs to displaced, wide-field amacrine
cells, potentially enabling ipRGCs to regulate the secretion of
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neuromodulators in displaced amacrine cells (Reifler et al.,
2015).
Cx30.2 is Expressed in AII Amacrine Cells
of the Mouse Retina
Among the Cx30.2-expressing neurons in the INL, we found
AII amacrine cells. Dye-injecting pre-labeled β-gal-positive
neurons revealed the distinctive AII morphology with lobular
appendages in the OFF- and arboreal dendrites in the ON-
sublamina of the IPL. Disabled-1 staining, labeling only
AII cells in the mouse retina (Rice and Curran, 2000),
confirmed lacZ expression in the relay neurons of the primary
rod pathway. Also, the high density of β-gal-positive neurons
in the proximal INL (3500 cells/mm2, averaged over different
eccentricities) is consistent with expression in AII amacrines,
which represent the most numerous amacrine cell in the
mouse retina (∼2600 cells/mm2, Rice and Curran, 2000).
We also found lacZ expression in amacrine cells whose
somata were more distal than AII cell somata or between
AII somata, suggesting—together with the density difference
between lacZ-positive cells and AII cells—the presence of at least
one other Cx30.2-expressing amacrine cell type in the mouse
retina.
A Potential Regulatory Role for Cx30.2 in
AII Amacrine Cells?
We found Cx30.2 expression in AII amacrine cells and
demonstrated in HeLa cells that Cx30.2 and Cx36 are likely
able to assemble into the same gap junction channel. Therefore,
we analyzed whether the primary rod pathway was affected
in Cx30.2-deficient mice. However, ERG recordings and
tracer injections revealed no changes in b-wave amplitudes
or the number of cells coupled to the injected AII cell,
respectively. These data suggest that AII/AII amacrine
and AII/ON bipolar cell coupling are fully functional in
Cx30.2-deficient mice. Results are similar to data obtained
from hippocampal neurons which revealed—despite strong
expression of Cx30.2—no phenotype when Cx30.2 was
missing (Kreuzberg et al., 2008). As hippocampal neurons
and AII amacrine cells also express Cx36, lack of Cx30.2
may be compensated by Cx36. Therefore, we tested for
upregulation of Cx36 in Cx30.2-deficient mice but did
not find an increase in Cx36 immunoreactivity in the
IPL.
We also confirmed earlier results (Deans et al., 2002; Meyer
et al., 2014) that lack of Cx36 completely abolished coupling
in AII amacrine cells. As HeLa cell transfections revealed
significantly smaller gap junction plaques for Cx30.2 than for
Cx36, Cx36-deficient AII cells may not form enough Cx30.2
gap junction channels to allow for tracer to spread from
one cell to another. This is supported by ERG recordings
which showed dramatically reduced b-wave amplitudes in
Cx36-deficient mice, suggesting that residual electrical coupling
between AII cells and ON bipolar cells by Cx30.2 homomers
is rather unlikely. Yet, as we cannot determine the subcellular
localization of Cx30.2, we cannot completely exclude that
Cx30.2 forms homomeric channels in AII cells. This could
be the case if Cx30.2 and Cx36 or Cx45 were transported
to different compartments or different gap junctional plaques
within the AII cell or assembled into bihomotypic gap
junction plaques as suggested for Cx36 and Cx45 (Li et al.,
2008).
Cx36 and Cx30.2 exhibit a low sensitivity to changes
in transjunctional voltage and have a rather low unitary
conductance (Cx30.2: 9 pS; Cx36: 14 pS; Teubner et al., 2000;
Kreuzberg et al., 2005), suggesting that they have quite similar
properties. However, both connexins differ in the kinases they
are phosphorylated by: in the retina, Cx30.2 was shown to be
modulated by protein kinase C (PKC; Müller et al., 2010a) and
also contains a putative protein kinase G (PKG) phosphorylation
site. In contrast, Cx36 is phosphorylated by CamKII (Kothmann
et al., 2012). Similarly, the two sets of gap junctions formed
by AII cells (AII/AII and AII/ON bipolar cell gap junctions)
are differentially regulated (Mills and Massey, 1995). Thus, it
is tempting to speculate that Cx30.2 may provide a substrate
for the differential regulation of gap junctions in AII amacrine
cells, rendering AII gap junctions (or maybe even only one of
its two sets) sensitive to PKC- or PKG-mediated regulation.
If this is indeed the function of Cx30.2, why do we not see
altered dye coupling? Phosphorylation of gap junctions is not a
global process in AII cells but occurs rather locally, differentially
affecting individual gap junction plaques as shown by Kothmann
et al. (2009). Thus, we believe that evaluating global tracer
coupling is not sensitive enough to detect the minor differences
in gap junction conductance that are to be expected by changes
in phosphorylation. Moreover, AII amacrine cells are coupled to
most if not all types of ON bipolar cells (Veruki and Hartveit,
2002), which differ in their physiology. It seems therefore
conceivable that gap junctional signal transmission from AII
cells is not the same for all ON bipolar cell types but slightly
differs between types, for example by connexin composition or
phosphorylation state.
Cx30.2 is widespread in neurons in the inner retina and can
interact with Cx36 inHeLa cells. In AII amacrine cells, we suggest
that Cx30.2 may confer sensitivity to PKC-mediated pathways
to the electrical synapse and thus provide a means for dynamic
regulation of electrical signal transmission between rod and cone
pathways.
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